In contrast, in a study of small cell lung carcinomas in which 48% of tumors expressed SSTR2, high SSTR2 expression (defined in that study as SSTR2 expression in tumor tissue 1+ or greater or immunohistochemical score ≥ 1) was associated with worse 2-year survival when compared to low expression of SSTR2 (21). This evidence concerns the gene SSTR2 and neoplasm.